CytomX Therapeutics (CTMX) Net Cash Flow (2016 - 2025)
Historic Net Cash Flow for CytomX Therapeutics (CTMX) over the last 12 years, with Q3 2025 value amounting to -$14.9 million.
- CytomX Therapeutics' Net Cash Flow fell 48008.59% to -$14.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.4 million, marking a year-over-year decrease of 14358.2%. This contributed to the annual value of $21.0 million for FY2024, which is 11189.43% up from last year.
- Per CytomX Therapeutics' latest filing, its Net Cash Flow stood at -$14.9 million for Q3 2025, which was down 48008.59% from $1.4 million recorded in Q2 2025.
- Over the past 5 years, CytomX Therapeutics' Net Cash Flow peaked at $137.8 million during Q1 2021, and registered a low of -$137.3 million during Q1 2023.
- In the last 5 years, CytomX Therapeutics' Net Cash Flow had a median value of -$8.9 million in 2023 and averaged -$8.3 million.
- Per our database at Business Quant, CytomX Therapeutics' Net Cash Flow soared by 49898.22% in 2024 and then plummeted by 48008.59% in 2025.
- Quarter analysis of 5 years shows CytomX Therapeutics' Net Cash Flow stood at -$30.8 million in 2021, then soared by 420.66% to $98.6 million in 2022, then plummeted by 108.98% to -$8.9 million in 2023, then soared by 71.49% to -$2.5 million in 2024, then tumbled by 488.59% to -$14.9 million in 2025.
- Its Net Cash Flow stands at -$14.9 million for Q3 2025, versus $1.4 million for Q2 2025 and $9.6 million for Q1 2025.